A company developing needle-free vaccination tech just raised $25 million

chevron_leftPreviosly
Nanopatch vaccine technology company attracts $25 million
10 February 2015
Nextchevron_right
Vaxxas raises $25m in Series B financing
10 February 2015

You may also like

10 March 2016

Forget unicorns: ‘Dragons’ are the Australian startup problem no one’s talking about

10 November 2021

Victorian startups will soon be able to pitch themselves to one of Australia’s leading VC firms as part of a $30 million government initiative

10 February 2015

A company developing needle-free vaccination tech just raised $25 million

04 December 2017

“As big as the internet”: Why this venture capitalist says blockchain technology and “cryptoassets” are the future of fintech

View All

Ventured. Gained.

Subscribe to our Newsletter for the latest updates from 1V.

decor decor decor
decor decor decor decor decor